Cellva Raises R$8.5 Million to Expand Operations and International Presence

Cellva Ingredients, a company in Latin America focused on developing and producing nutraceutical and food bioingredients, has secured R$8.5 million in a recent fundraising round. The investment was supported by funds such as Proveg, Rumbo Ventures, AirCapital, Fundepar, and EA Angels, along with 151 investors from the Captable platform.

This funding will be directed toward expanding Cellva’s production capabilities, hiring additional specialized staff, and advancing the company’s international operations. The CEO, Sérgio Pinto, indicated that the funds are crucial for meeting the rising demand for healthier and more sustainable food options.

Cellva plans to increase its production capacity to 10 tons per month by early 2026. The company is also investing in research and development to improve its microcarrier and microsphere technologies, which have potential applications in the pharmaceutical and cosmetic sectors.

The company is preparing to expand its presence in international markets, with a particular focus on regions with high demand for sustainable food solutions. Cellva has established initial partnerships with major food ingredient companies, facilitating its entry into markets such as the United States.

This recent round follows a previous funding effort in February 2024, which raised R$6.5 million. Combined, these investments are expected to significantly enhance Cellva’s ability to bring its bioingredient products to a broader market, including microcarriers for pharmaceuticals, microcapsules for ingredient protection and fat reduction, and essential fatty acids derived from cultivated fat.